Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
Chemtos, LLC has submitted a formal application to the U.S. Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of one or more basic classes of controlled substances. This registration, if granted, would authorize the company to produce controlled substances at a commercial or industrial scale under federal oversight. Under the Controlled Substances Act (CSA), any entity seeking to manufacture controlled substances must obtain DEA registration. The DEA publishes such applications in the Federal Register to allow the public, law enforcement, and other stakeholders to submit comments or objections within the applicable comment period. This notice does not constitute approval of the application. The DEA will review the application, consider any public comments, and make a determination based on public interest, safety, and compliance with federal drug manufacturing regulations.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Chemtos, LLC has applied for DEA registration as a bulk manufacturer of controlled substances as of March 30, 2026
- Application covers one or more basic classes of controlled substances (specific drug classes not disclosed in notice)
- Federal Register publication opens a public comment and objection period for stakeholders
+ 2 more changes with Pro
Obligations
What this law requires
Chemtos, LLC must obtain DEA registration as a bulk manufacturer of controlled substances before commencing manufacturing operations
Chemtos, LLC must comply with all federal drug manufacturing regulations as a condition of DEA registration
Chemtos, LLC must submit a formal application to the DEA containing required information for bulk manufacturer registration review
The DEA must publish the application in the Federal Register to allow public comment and objections during the applicable comment period
The DEA must review the application and consider public comments before making a registration determination